 | • レポートコード：GIR201105144 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、髄膜腫薬の世界市場を調査対象にし、髄膜腫薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アベマシクリブ、ジマレイン酸アファチニブ、AR-42、アベルマブ、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Arno Therapeutics Inc、Merck KGaA、Eli Lilly and Co、AstraZeneca Plc、Merck & Co Inc、Boehringer Ingelheim GmbH、Ono Pharmaceutical Co Ltd、GlaxoSmithKline Plc、Genentech Inc、Novartis AG、Pharma Mar SA、Progenics Pharmaceuticals Inc ・メーカー別販売量、売上、市場シェア ・髄膜腫薬の地域別市場分析 ・髄膜腫薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・髄膜腫薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・髄膜腫薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・髄膜腫薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・髄膜腫薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・髄膜腫薬の種類別市場規模2015-2020：アベマシクリブ、ジマレイン酸アファチニブ、AR-42、アベルマブ、その他 ・髄膜腫薬の用途別市場規模2015-2020：病院、クリニック、その他 ・髄膜腫薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Meningioma Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Meningioma Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Meningioma Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Meningioma Drug market has been segmented into
Abemaciclib
Afatinib Dimaleate
AR-42
Avelumab
Others
By Application, Meningioma Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Meningioma Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Meningioma Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Meningioma Drug market.
The report offers in-depth assessment of the growth and other aspects of the Meningioma Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Meningioma Drug Market Share Analysis
Meningioma Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Meningioma Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Meningioma Drug sales, revenue and market share for each player covered in this report.
The major players covered in Meningioma Drug are:
Arno Therapeutics Inc
Merck KGaA
Eli Lilly and Co
AstraZeneca Plc
Merck & Co Inc
Boehringer Ingelheim GmbH
Ono Pharmaceutical Co Ltd
GlaxoSmithKline Plc
Genentech Inc
Novartis AG
Pharma Mar SA
Progenics Pharmaceuticals Inc
Among other players domestic and global, Meningioma Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningioma Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningioma Drug, with price, sales, revenue and global market share of Meningioma Drug in 2018 and 2019.
Chapter 3, the Meningioma Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningioma Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Meningioma Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Meningioma Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Meningioma Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meningioma Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Abemaciclib
1.2.3 Afatinib Dimaleate
1.2.4 AR-42
1.2.5 Avelumab
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Meningioma Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Meningioma Drug Market
1.4.1 Global Meningioma Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Arno Therapeutics Inc
2.1.1 Arno Therapeutics Inc Details
2.1.2 Arno Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Arno Therapeutics Inc SWOT Analysis
2.1.4 Arno Therapeutics Inc Product and Services
2.1.5 Arno Therapeutics Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck KGaA SWOT Analysis
2.2.4 Merck KGaA Product and Services
2.2.5 Merck KGaA Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly and Co
2.3.1 Eli Lilly and Co Details
2.3.2 Eli Lilly and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly and Co SWOT Analysis
2.3.4 Eli Lilly and Co Product and Services
2.3.5 Eli Lilly and Co Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca Plc
2.4.1 AstraZeneca Plc Details
2.4.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca Plc SWOT Analysis
2.4.4 AstraZeneca Plc Product and Services
2.4.5 AstraZeneca Plc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Co Inc
2.5.1 Merck & Co Inc Details
2.5.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck & Co Inc SWOT Analysis
2.5.4 Merck & Co Inc Product and Services
2.5.5 Merck & Co Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim GmbH
2.6.1 Boehringer Ingelheim GmbH Details
2.6.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim GmbH SWOT Analysis
2.6.4 Boehringer Ingelheim GmbH Product and Services
2.6.5 Boehringer Ingelheim GmbH Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ono Pharmaceutical Co Ltd
2.7.1 Ono Pharmaceutical Co Ltd Details
2.7.2 Ono Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ono Pharmaceutical Co Ltd SWOT Analysis
2.7.4 Ono Pharmaceutical Co Ltd Product and Services
2.7.5 Ono Pharmaceutical Co Ltd Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline Plc
2.8.1 GlaxoSmithKline Plc Details
2.8.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline Plc SWOT Analysis
2.8.4 GlaxoSmithKline Plc Product and Services
2.8.5 GlaxoSmithKline Plc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech Inc
2.9.1 Genentech Inc Details
2.9.2 Genentech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genentech Inc SWOT Analysis
2.9.4 Genentech Inc Product and Services
2.9.5 Genentech Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis AG SWOT Analysis
2.10.4 Novartis AG Product and Services
2.10.5 Novartis AG Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pharma Mar SA
2.11.1 Pharma Mar SA Details
2.11.2 Pharma Mar SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pharma Mar SA SWOT Analysis
2.11.4 Pharma Mar SA Product and Services
2.11.5 Pharma Mar SA Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Progenics Pharmaceuticals Inc
2.12.1 Progenics Pharmaceuticals Inc Details
2.12.2 Progenics Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Progenics Pharmaceuticals Inc SWOT Analysis
2.12.4 Progenics Pharmaceuticals Inc Product and Services
2.12.5 Progenics Pharmaceuticals Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Meningioma Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Meningioma Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Meningioma Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Meningioma Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Meningioma Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Meningioma Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Meningioma Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Meningioma Drug Sales and Growth Rate (2015-2020)
4.3 Europe Meningioma Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Meningioma Drug Sales and Growth Rate (2015-2020)
4.5 South America Meningioma Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Meningioma Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Meningioma Drug Sales, Revenue and Market Share by Country
5.1.1 North America Meningioma Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Meningioma Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Meningioma Drug Sales and Growth Rate (2015-2020)
5.3 Canada Meningioma Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Meningioma Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Meningioma Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Meningioma Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Meningioma Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Meningioma Drug Sales and Growth Rate (2015-2020)
6.3 UK Meningioma Drug Sales and Growth Rate (2015-2020)
6.4 France Meningioma Drug Sales and Growth Rate (2015-2020)
6.5 Russia Meningioma Drug Sales and Growth Rate (2015-2020)
6.6 Italy Meningioma Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Meningioma Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Meningioma Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Meningioma Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Meningioma Drug Sales and Growth Rate (2015-2020)
7.3 Japan Meningioma Drug Sales and Growth Rate (2015-2020)
7.4 Korea Meningioma Drug Sales and Growth Rate (2015-2020)
7.5 India Meningioma Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Meningioma Drug Sales and Growth Rate (2015-2020)
7.7 Australia Meningioma Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Meningioma Drug Sales, Revenue and Market Share by Country
8.1.1 South America Meningioma Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Meningioma Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Meningioma Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Meningioma Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Meningioma Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Meningioma Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Meningioma Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Meningioma Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Meningioma Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Meningioma Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Meningioma Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Meningioma Drug Sales and Market Share by Type (2015-2020)
10.2 Global Meningioma Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Meningioma Drug Price by Type (2015-2020)
11 Global Meningioma Drug Market Segment by Application
11.1 Global Meningioma Drug Sales Market Share by Application (2015-2020)
11.2 Global Meningioma Drug Revenue Market Share by Application (2015-2020)
11.3 Global Meningioma Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Meningioma Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Meningioma Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Meningioma Drug Market Forecast (2021-2025)
12.2.2 Europe Meningioma Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Meningioma Drug Market Forecast (2021-2025)
12.2.4 South America Meningioma Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Meningioma Drug Market Forecast (2021-2025)
12.3 Meningioma Drug Market Forecast by Type (2021-2025)
12.3.1 Global Meningioma Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Meningioma Drug Market Share Forecast by Type (2021-2025)
12.4 Meningioma Drug Market Forecast by Application (2021-2025)
12.4.1 Global Meningioma Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Meningioma Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Meningioma Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Meningioma Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Meningioma Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Arno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Arno Therapeutics Inc Meningioma Drug Major Business
Table 9. Arno Therapeutics Inc Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 10. Arno Therapeutics Inc SWOT Analysis
Table 11. Arno Therapeutics Inc Meningioma Drug Product and Services
Table 12. Arno Therapeutics Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 14. Merck KGaA Meningioma Drug Major Business
Table 15. Merck KGaA Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 16. Merck KGaA SWOT Analysis
Table 17. Merck KGaA Meningioma Drug Product and Services
Table 18. Merck KGaA Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Co Meningioma Drug Major Business
Table 21. Eli Lilly and Co Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 22. Eli Lilly and Co SWOT Analysis
Table 23. Eli Lilly and Co Meningioma Drug Product and Services
Table 24. Eli Lilly and Co Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Plc Meningioma Drug Major Business
Table 27. AstraZeneca Plc Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 28. AstraZeneca Plc SWOT Analysis
Table 29. AstraZeneca Plc Meningioma Drug Product and Services
Table 30. AstraZeneca Plc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 32. Merck & Co Inc Meningioma Drug Major Business
Table 33. Merck & Co Inc Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 34. Merck & Co Inc SWOT Analysis
Table 35. Merck & Co Inc Meningioma Drug Product and Services
Table 36. Merck & Co Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim GmbH Meningioma Drug Major Business
Table 39. Boehringer Ingelheim GmbH Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 40. Boehringer Ingelheim GmbH SWOT Analysis
Table 41. Boehringer Ingelheim GmbH Meningioma Drug Product and Services
Table 42. Boehringer Ingelheim GmbH Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Ono Pharmaceutical Co Ltd Meningioma Drug Major Business
Table 45. Ono Pharmaceutical Co Ltd Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 46. Ono Pharmaceutical Co Ltd SWOT Analysis
Table 47. Ono Pharmaceutical Co Ltd Meningioma Drug Product and Services
Table 48. Ono Pharmaceutical Co Ltd Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Plc Meningioma Drug Major Business
Table 51. GlaxoSmithKline Plc Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 52. GlaxoSmithKline Plc SWOT Analysis
Table 53. GlaxoSmithKline Plc Meningioma Drug Product and Services
Table 54. GlaxoSmithKline Plc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 56. Genentech Inc Meningioma Drug Major Business
Table 57. Genentech Inc Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 58. Genentech Inc SWOT Analysis
Table 59. Genentech Inc Meningioma Drug Product and Services
Table 60. Genentech Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Meningioma Drug Major Business
Table 63. Novartis AG Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 64. Novartis AG SWOT Analysis
Table 65. Novartis AG Meningioma Drug Product and Services
Table 66. Novartis AG Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pharma Mar SA Basic Information, Manufacturing Base and Competitors
Table 68. Pharma Mar SA Meningioma Drug Major Business
Table 69. Pharma Mar SA Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 70. Pharma Mar SA SWOT Analysis
Table 71. Pharma Mar SA Meningioma Drug Product and Services
Table 72. Pharma Mar SA Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 74. Progenics Pharmaceuticals Inc Meningioma Drug Major Business
Table 75. Progenics Pharmaceuticals Inc Meningioma Drug Total Revenue (USD Million) (2018-2019)
Table 76. Progenics Pharmaceuticals Inc SWOT Analysis
Table 77. Progenics Pharmaceuticals Inc Meningioma Drug Product and Services
Table 78. Progenics Pharmaceuticals Inc Meningioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Meningioma Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 80. Global Meningioma Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Meningioma Drug Sales by Regions (2015-2020) (K Pcs)
Table 82. Global Meningioma Drug Sales Market Share by Regions (2015-2020)
Table 83. Global Meningioma Drug Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Meningioma Drug Sales by Countries (2015-2020) (K Pcs)
Table 85. North America Meningioma Drug Sales Market Share by Countries (2015-2020)
Table 86. North America Meningioma Drug Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Meningioma Drug Revenue Market Share by Countries (2015-2020)
Table 88. Europe Meningioma Drug Sales by Countries (2015-2020) (K Pcs)
Table 89. Europe Meningioma Drug Sales Market Share by Countries (2015-2020)
Table 90. Europe Meningioma Drug Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Meningioma Drug Sales by Regions (2015-2020) (K Pcs)
Table 92. Asia-Pacific Meningioma Drug Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Meningioma Drug Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Meningioma Drug Sales by Countries (2015-2020) (K Pcs)
Table 95. South America Meningioma Drug Sales Market Share by Countries (2015-2020)
Table 96. South America Meningioma Drug Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Meningioma Drug Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Meningioma Drug Sales by Countries (2015-2020) (K Pcs)
Table 99. Middle East & Africa Meningioma Drug Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Meningioma Drug Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Meningioma Drug Revenue Market Share by Countries (2015-2020)
Table 102. Global Meningioma Drug Sales by Type (2015-2020) (K Pcs)
Table 103. Global Meningioma Drug Sales Share by Type (2015-2020)
Table 104. Global Meningioma Drug Revenue by Type (2015-2020) (USD Million)
Table 105. Global Meningioma Drug Revenue Share by Type (2015-2020)
Table 106. Global Meningioma Drug Sales by Application (2015-2020) (K Pcs)
Table 107. Global Meningioma Drug Sales Share by Application (2015-2020)
Table 108. Global Meningioma Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 109. Global Meningioma Drug Market Share Forecast by Regions (2021-2025)
Table 110. Global Meningioma Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 111. Global Meningioma Drug Market Share Forecast by Type (2021-2025)
Table 112. Global Meningioma Drug Sales Forecast by Application (2021-2025)
Table 113. Global Meningioma Drug Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Meningioma Drug Picture
Figure 2. Global Sales Market Share of Meningioma Drug by Type in 2019
Figure 3. Abemaciclib Picture
Figure 4. Afatinib Dimaleate Picture
Figure 5. AR-42 Picture
Figure 6. Avelumab Picture
Figure 7. Others Picture
Figure 8. Meningioma Drug Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Meningioma Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Meningioma Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Meningioma Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Meningioma Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Meningioma Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Meningioma Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Meningioma Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Meningioma Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Meningioma Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Meningioma Drug Revenue Market Share by Regions in 2018
Figure 41. North America Meningioma Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Meningioma Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Meningioma Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Meningioma Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Meningioma Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Meningioma Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Meningioma Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Meningioma Drug Sales Market Share by Countries in 2018
Figure 49. North America Meningioma Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Meningioma Drug Revenue Market Share by Countries in 2018
Figure 51. United States Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Meningioma Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Meningioma Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Meningioma Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Meningioma Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Meningioma Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Meningioma Drug Revenue Market Share by Regions 2019
Figure 65. China Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Meningioma Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Meningioma Drug Sales Market Share by Countries in 2019
Figure 72. South America Meningioma Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Meningioma Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Meningioma Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Meningioma Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Meningioma Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Meningioma Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Meningioma Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Meningioma Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Meningioma Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Meningioma Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Meningioma Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Meningioma Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Meningioma Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
上衣腫治療薬の世界市場 2020年 Market Overview The global Ependymoma Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ependymoma Drug market report…- 甲状腺機能低下症治療の世界市場 2020年 Market Overview The global Hypothyroidism Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hypothyroidism Drug marke…
- スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…
- ポンチングリオーマ薬の世界市場 2020年 Market Overview The global Pontine Glioma Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pontine Glioma Drug marke…
- 小売用医薬品の世界市場 2020年 Market Overview The global Retail Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1350.1 million by 2025, from USD 1211 million in 2019. The Retail Drug market report …